Maarten Ooms

Research output

Research output per year 2019 2021 2022 2025

• 18 In-proceedings paper
• 17 Article
• 2 Literature review
• 1 ER - External report
• 2 More
  • 1 Chapter
  • 1 Special issue

Research output per year

Research output per year

Search results

• 2025

  Cysteine-selective [¹⁸⁸Re]Re(v) radiolabelling of a Nanobody® for targeted radionuclide therapy using a “chelate-then-click” approach

  Melis, D. R., Segers, C., Wellens, J., Van de Voorde, M., Blacque, O., Ooms, M., Gasser, G. & Opsomer, T., 26 Feb 2025, In: Chemical Science. p. 10

  Research output › peer-review

  Open Access

• Mitochondria-tropic radioconjugates to enhance the therapeutic potential of terbium-161

  Santos, J. F., Laere, C. V., Silva, C. D., Cassells, I., Fernandes, C., Raposinho, P., Belchior, A., Pinto, C. I. G., Mendes, F., Cawthorne, C., Ooms, M., Voorde, M. V. D., Cleeren, F. & Paulo, A., Dec 2025, In: EJNMMI Radiopharmacy and Chemistry. 10, 1, 15 p., 18.

  Research output › peer-review

  Open Access
• 2024

  Preclinical evaluation of MC1R targeting theranostic pair [¹⁵⁵Tb]Tb-crown-αMSH and [¹⁶¹Tb]Tb-crown-αMSH

  Wharton, L., McNeil, S. W., Zhang, C., Engudar, G., Van de Voorde, M., Zeisler, J., Koniar, H., Sekar, S., Yuan, Z., Schaffer, P., Radchenko, V., Ooms, M., Kunz, P., Bénard, F. & Yang, H., Sep 2024, In: Nuclear Medicine and Biology. 136-137, 11 p., 108925.

  Research output › peer-review

  Open Access

• Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development

  Koniar, H., McNeil, S., Wharton, L., Ingham, A., van de Voorde, M., Ooms, M., Sekar, S., Rodriguez-Rodriguez, C., Kunz, P., Radchenko, V., Rahmim, A., Uribe, C., Yang, H. & Schaffer, P., Dec 2024, In: EJNMMI Physics. 11, 1, 18 p., 77.

  Research output › peer-review

  Open Access

• Targeted radiopharmaceuticals: an underexplored strategy for ovarian cancer

  Crabbé, M., Opsomer, T., Vermeulen, K., Ooms, M. & Segers, C., 2024, In: Theranostics. 14, 16, p. 6281-6300 20 p.

  Research output › peer-review

  Open Access

• Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside

  Van Laere, C., Koole, M., Deroose, C. M., Van de Voorde, M., Baete, K., Cocolios, T. E., Duchemin, C., Ooms, M. & Cleeren, F., 17 Feb 2024, In: Theranostics. 14, 4, p. 1720-1743 24 p.

  Research output › peer-review

  Open Access
• 2023

  3p-C-NETA-TATE: a theranostic somatostatin analogue targeting neuroendocrine tumors

  Ahenkorah, S., Murce, E., Cawthorne, C., Seimbille, Y., Cardinaels, T., Deroose, C., Bormans, G., Ooms, M. & Cleeren, F., 15 Jun 2023, Abstracts from the 20th European symposium on radiopharmacy and radiopharmaceuticals. 1 ed. Springer, Vol. 8. p. 6-6 1 p. OP13. (EJNMMI Radiopharmacy and Chemistry ; vol. 8, no. Supplement 1).

  Research output › peer-review

  Open Access

• Comparative Study of a Decadentate Acyclic Chelate, HOPO‑O10, and Its Octadentate Analogue, HOPO‑O8, for Radiopharmaceutical Applications

  Carbo-Bague, I., Li, C., McNeil, B. L., Gao, Y., McDonagh, A. W., Van de Voorde, M., Ooms, M., Kunz, P., Yang, H., Radchenko, V., Schreckenbach, G. & Ramogida, C. F., 18 Dec 2023, In: Inorganic Chemistry. 62, 50, p. 20549-20566 18 p., 2c03671.

  Research output › peer-review

  Open Access

• Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist

  Ahenkorah, S., Cawthorne, C., Murce, E., Deroose, C., Cardinaels, T., Seimbille, Y., Bomans, G., Ooms, M. & Cleeren, F., 1 Mar 2023, In: Nuclear Medicine and Biology. 118-119, 10 p., 108338.

  Research output › peer-review

  Open Access

• P-232 - Nanosized crystalline vehicle for targeted radionuclide therapy

  Lemaître, T., Opsomer, T., Ooms, M., Burgoyne, A., Van de Voorde, M., Cardinaels, T. & Parac-Vogt, T. N., 1 Dec 2023, Nuclear Medicine and Biology: Abstracts of the International Symposium on Radiopharmaceutical Sciences iSRS 2023. Supplement ed. Elsevier, Vol. 126–127. p. S226 1 p. 108696. (Nuclear Medicine and Biology; vol. 126-127).

  Research output › peer-review

  Open Access

• P-260 - Validating the impact of metal contaminants on the radiolabeling of DOTATATE with 161Tb

  Opsomer, T., Vermeulen, K., Van de Voorde, M., Ramaekers, S., Segers, C., Coolkens, A. & Ooms, M., 1 Dec 2023, Nuclear Medicine and Biology: Abstracts of the International Symposium on Radiopharmaceutical Sciences iSRS 2023. Supplement ed. Elsevier, Vol. 126–127. p. S246-S247 2 p. 108723. (Nuclear Medicine and Biology; vol. 126-127).

  Research output › peer-review

• Preclinical evaluation of [155/161Tb] Tb-Crown-TATE - a novel SPECT imaging theranostic agent targeting neuroendocrine tumours

  Wharton, L., McNeil, S. W., Merkens, H., Yuan, Z., Van de Voorde, M., Engudar, G., Ingham, A., Koniar, H., Rodriguez-Rodriguez, C., Radchenko, V., Ooms, M., Kunz, P., Bénard, F., Schaffer, P. & Yang, H., Apr 2023, In: Molecules. 28, 7, 16 p., 3155.

  Research output › peer-review

  Open Access
• 2022

  3p-C-NETA: A versatile and effective chelator for development of Al¹⁸F-labeled and therapeutic radiopharmaceuticals

  Ahenkorah, S., Murce, E., Cawthorne, C., Ketchemen, J. P., Deroose, C. M., Cardinaels, T., Seimbille, Y., Fonge, H., Gsell, W., Bormans, G., Ooms, M. & Cleeren, F., 2022, In: Theranostics. 12, 13, p. 5971-5985 15 p.

  Research output › peer-review

  Open Access
  7 Scopus citations

• 3p-C-NETA-TATE: a versatile somatostatin analogue for Al18F-labeled and therapeutic SSTR2 targeting radiopharmaceuticals

  Ahenkorah, S., Murce, E., Ketchemen, J., Cawthorne, C., Seimbille, Y., Cardinaels, T., Bormans, G., Fonge, H., Ooms, M. & Cleeren, F., May 2022, Abstracts of the International Symposium on Radiopharmaceutical Sciences iSRS 2022. Supplement ed. Elsevier, Vol. 108-109. p. S10-S11 2 p. O-11. (Nuclear Medicine and Biology).

  Research output › peer-review

  Open Access

• A simple and automated method for 161Tb purification and ICP‑MS analysis of 161Tb

  McNeil, S. W., Van de Voorde, M., Zhang, C., Ooms, M., Bénard, F., Radchenko, V. & Yang, H., 2 Dec 2022, In: EJNMMI Radiopharmacy and Chemistry. 7, 17 p., 31.

  Research output › peer-review

  Open Access

• Bifunctional chelators for radiorhenium: past, present and future outlook

  Melis, D., Burgoyne, A., Ooms, M. & Gasser, G., 14 Jan 2022, In: RSC Medicinal Chemistry. 13, 3, p. 217-245 29 p.

  Research output › peer-review

  Open Access

• Development of an in-house 188W/188Re generator for rhenium-188 production and radiolabelling studies

  Melis, D., Opsomer, T., Ponsard, B., Burgoyne, A., Gasser, G., Van de Voorde, M. & Ooms, M., Dec 2022, Nuclear Medicine and Biology: Abstracts of the Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022). Elsevier, Vol. 114-115/S. p. S38 1 p. P-11. (Nuclear Medicine and Biology; vol. 114-115/S).

  Research output › peer-review

  Open Access

• Development of targeted 161Tb-radiolabeled nanoparticles

  Lemaître, T., Ooms, M., Opsomer, T., Van de Voorde, M., Cardinaels, T. & Parac-Vogt, T. N., 1 Dec 2022, Nuclear Medicine and Biology: Abstracts of the Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022). Elsevier, Vol. 114-115/S. p. S69 1 p. P-73. (Nuclear Medicine and Biology; vol. 114-115/S).

  Research output › peer-review

  Open Access

• Effect of metal impurities on the radiolabeling efficiency of DOTA with terbium-161 and lutetium-177: a comparative study

  Opsomer, T., Van de Voorde, M., Vermeulen, K., Ramaekers, S., Burgoyne, A. & Ooms, M., 8 Dec 2022, Nuclear Medicine and Biology: Abstracts of the Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022). 2022 ed. Elsevier, Vol. 114-115/S. p. S57-S58 2 p. P-53. (Nuclear Medicine and Biology; vol. 114-115/S).

  Research output › peer-review

  Open Access

• Evaluating the in vivo distribution and stability of a 161Tb-labeled nanobody for potential cancer therapy

  Cassells, I., Van de Voorde, M., Vermeulen, K., Rodriguez Pérez, S., Segers, C., Cawthorne, C., Deroose, C., Cardinaels, T., Bormans, G., Ooms, M. & Cleeren, F., 8 Dec 2022, Nuclear Medicine and Biology: Abstracts of the Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022). Elsevier, Vol. 114-115/S. p. S50 1 p. P-37. (Nuclear Medicine and Biology; vol. 114-115/S).

  Research output › peer-review

  Open Access

• Evaluation of 3p-C-DEPA as potential 225Ac-chelator

  Ahenkorah, S., Ramdhani, D., Deroose, C., Cardinaels, T., Bormans, G., Cleeren, F. & Ooms, M., 8 Dec 2022, Nuclear Medicine and Biology: Abstracts of the Fourth International Symposium on Technetium and Other Radiometals in Chemistry and Medicine (TERACHEM 2022). Elsevier, Vol. 114-115/S. p. S49 1 p. P-35. (Nuclear Medicine and Biology; vol. 114-115S).

  Research output › peer-review

  Open Access

• Exploring the potential of high-molar activity Samarium-153 for targeted radionuclide therapy with [153Sm]Sm-DOTA-TATE

  Vermeulen, K., Van de Voorde, M., Segers, C., Coolkens, A., Rodriguez Perez, S., Duchemin, C., Crabbé, M., Opsomer, T., Saldarriaga Vargas, C., Reinhard, H., Lambert, L., Bernerd, C., Burgoyne, A., Cocolios, T. E., Stora, T. & Ooms, M., 18 Nov 2022, In: Pharmaceutics. 14, p. 1-15 15 p., 2566.

  Research output › peer-review

  Open Access

• Gamma counting protocols for the accurate quantification of 225Ac and 213Bi without the need for a secular equilibrium between parent and gamma‑emitting daughter

  Castillo, D., De Saint-Hubert, M., Ahenkorah, S., Saldarriaga Vargas, C., Ooms, M., Struelens, L. & Koole, M., 23 Oct 2022, In: EJNMMI Radiopharmacy and Chemistry. 7, 28, 17 p., 28.

  Research output › peer-review

  Open Access

• Inorganic Radiolabeled Nanomaterials in Cancer Therapy: A Review

  Lemaître, T., Burgoyne, A., Ooms, M., Parac-Vogt, T. N. & Cardinaels, T., 22 Jun 2022, In: ACS Applied Nano Materials. 5, 7, p. 8560-8709 30 p.

  Research output › peer-review

  Open Access

• Mild condition radiolabelling and in vivo stability of nanobody constructs with terbium-161 and terbium-155

  Cassells, I., Van de Voorde, M., Webster, B., Ivanov, P., Burgoyne, A., Cawthorne, C., Deroose, C., Cardinaels, T., Bormans, G., Cleeren, F. & Ooms, M., 22 May 2022, Nuclear Medicine and Biology. Supplement ed. Elsevier, Vol. 108-109. p. S53-S54 2 p. P-004. (Nuclear Medicine and Biology; vol. 108).

  Research output › peer-review

  Open Access

• O-27 - Using high-specific activity Samarium-153 for the development of [153Sm] Sm DOTA-TATE for targeted radionuclide therapy of neuroendocrine tumors

  Vermeulen, K., Van de Voorde, M., Daems, N., Duchemin, C., Rodriguez Pérez, S., Crabbé, M., Reinhard, H., Ponsard, B., Geenen, L., Nonnekens, J., Lambert, L., Bernerd, C., Burgoyne, A., Cocolios, T. E., Stora, T. & Ooms, M., May 2022, In: Nuclear Medicine and Biology. 108-109, Supplement, p. S20 1 p.

  Research output › peer-review

  Open Access
• 2021

  Al18F-3p-C-NETA-TATE: Combining a versatile and highly effective chelator with an established somatostatin analogue

  Ahenkorah, S., Murce, E., Seimbille, Y., Cardinaels, T., Deroose, C., Bormans, G., Ooms, M. & Cleeren, F., 24 Sep 2021, European Journal of Nuclear Medicine and Molecular Imaging: European Association of Nuclear Medicine October 20-23, 2021 Virtual. Springer, Vol. 48. p. S195-S196 1 p. OP-0556. (European Journal of Nuclear Medicine and Molecular Imaging; vol. 48, no. Supplement Issue 1).

  Research output › peer-review

  Open Access

• Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside

  Ahenkorah, S., Cassells, I., Deroose, C., Cardinaels, T., Burgoyne, A., Bormans, G., Ooms, M. & Cleeren, F., 21 Apr 2021, In: Pharmaceutics. 13, 599, p. 1-25 25 p., 599.

  Research output › peer-review

  Open Access

• PET Imaging of Phosphodiesterases in Brain

  Ooms, M. & Bormans, G., 3 Jan 2021, PET and SPECT of Neurobiological Systems. 2021 ed. Springer International Publishing, p. 851-877 27 p.

  Research output › peer-review

  Open Access

• Production of Sm-153 with high specific activity for targeted radionuclide therapy

  Van de Voorde, M., Duchemin, C., Reinhard, H., Lambert, L., Chevallay, E., Cocolios, T. E., Cardinaels, T., Ponsard, B., Ooms, M., Stora, T. & Burgoyne, A., 24 Sep 2021, European Journal of Nuclear Medicine and Molecular Imaging (2021): Annual Congress of the European Association of Nuclear Medicine, October 20-23, 2021. Supplement 1 ed. Springer, Vol. 48. p. S410-S410 1 p. ESP-050

  Research output › peer-review

  Open Access

• Production of Sm-153 With Very High Specific Activity for Targeted Radionuclide Therapy

  Van de Voorde, M., Duchemin, C., Reinhard, H., Lambert, L., Chevallay, E., Schneider, T., Van Stenis, M., Cocolios, T. E., Cardinaels, T., Ponsard, B., Ooms, M., Stora, T. & Burgoyne, A., 19 Jul 2021, In: Frontiers in Medicine. 8, p. 1-9 9 p., 675221.

  Research output › peer-review

  Open Access

• Radiolabeling of human serum albumin with terbium-161 using mild conditions and evaluation of in vivo Stability

  Cassells, I., Ahenkorah, S., Burgoyne, A., Van de Voorde, M., Deroose, C., Cardinaels, T., Bormans, G., Ooms, M. & Cleeren, F., 18 Aug 2021, In: Frontiers in Medicine. 8, p. 1-12 12 p., 675122.

  Research output › peer-review

  Open Access

• Separation of Lu from Yb for medical purposes: Assessment of Triskem process

  Dartiguelongue, A., Ramaekers, S. & Ooms, M., 16 Jun 2021, SCK CEN. 23 p. (SCK CEN Reports; no. ER-0986)

  Research output › peer-review

• 2020

  Development of an in-house 188W/188Re generator

  Van de Voorde, M., Burgoyne, A., Ponsard, B., Elema, D., Cardinaels, T. & Ooms, M., 30 Oct 2020, European Journal of Nuclear Medicine and Molecular Imaging. suppl. 1 ed. Vol. 47. p. 477 478 p. (European Journal of Nuclear Medicine and Molecular Imaging ; vol. 47, no. Supplement 1).

  Research output › peer-review

  Open Access

• Low temperature radiolabelling of human serum albumin constructs with terbium-161 and ex vivo biodistribution to assess in vivo stability

  Cassells, I., Ooms, M., Burgoyne, A., Cornelis, J., Ahenkorah, S., Van de Voorde, M., Cardinaels, T., Deroose, C., Bormans, G. & Cleeren, F., 30 Oct 2020, European Journal of Nuclear Medicine and Molecular Imaging. p. S753 1 p. OP-151. (European Journal of Nuclear Medicine and Molecular Imaging; vol. 47, no. Supplement 1).

  Research output › peer-review

  Open Access

• Radiolabeling with Tb-161 and Lu-177: defining the impact of metal impurities

  Ooms, M., Burgoyne, A., Ponsard, B., Elema, D., Cardinaels, T. & Van de Voorde, M., 30 Oct 2020, European Journal of Nuclear Medicine and Molecular Imaging. Supplement 1 ed. Vol. 47. p. 677 1 p. EP-340. (European Journal of Nuclear Medicine and Molecular Imaging ).

  Research output › peer-review

  Open Access

• Therapeutic Efficacy of 213 Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer

  Dekempeneer, Y., Caveliers, V., Ooms, M., Gysemans, M., Lahoutte, T., Xavier, C., Lecocq, Q., Maes, K., Covens, P., Miller, B. W., Bruchertseifer, F., Morgenstern, A., Cardinaels, T. & D'huyvetter, M., 19 Jul 2020, In: Molecular Pharmaceutics. 17, 9, p. 3553-3566 14 p.

  Research output › peer-review

  Open Access
• 2019

  161Tb Purification by High Performance Ion Chromatography (HPIC) from Irradiated 160Gd

  Ooms, M., Ponsard, B., Burgoyne, A., Elema, D. & Cardinaels, T., 31 Dec 2019, Annual Congress of the European Association of Nuclear Medicine October 12 – 16, 2019 Barcelona, Spain. Vol. 46. p. S40 1 p. (European Journal of Nuclear Medicine and Molecular Imaging).

  Research output › peer-review

  Open Access

• Radiolabeling of Gold Nanoparticles With Lu-177 as a Platform for Cancer Theranostics

  Daems, N., Ooms, M., Cardinaels, T., Baatout, S., Michiels, C., Lucas, S. & Aerts, A., 31 Dec 2019, Annual Congress of the European Association of Nuclear Medicine October 12 – 16, 2019 Barcelona, Spain. S1 ed. Vol. 46. p. S752 1 p. (European Journal of Nuclear Medicine and Molecular Imaging).

  Research output › peer-review

  Open Access

• Tb-161 Purification by high performance ion chromatography (HPIC) from irradiated Gd-160: Poster Category: Radiochemistry ‐ Radiometals

  Burgoyne, A., Ooms, M., Cardinaels, T. & Elema, D., 24 May 2019, Supplement: The 23rd International Symposium on Radiopharmaceutical Sciences (ISRS 2019) Beijing, China, 26–31 May 2019. Vol. 62. p. S303-S303 1 p. (Journal of Labelled Compounds and Radiopharmaceuticals).

  Research output › peer-review

  Open Access